Acuta Capital Partners’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-170,000
| Closed | -$4.32M | – | 61 |
|
|
2020
Q2 | $4.32M | Sell |
170,000
-86,500
| -34% | -$2.2M | 1.25% | 29 |
|
|
2020
Q1 | $4.71M | Sell |
256,500
-131,000
| -34% | -$2.41M | 2.28% | 18 |
|
|
2019
Q4 | $8.54M | Buy |
+387,500
| New | +$8.54M | 2.11% | 14 |
|
|
2019
Q3 | – | Sell |
-384,500
| Closed | -$6.06M | – | 37 |
|
|
2019
Q2 | $6.06M | Buy |
384,500
+55,675
| +17% | +$877K | 2.15% | 18 |
|
|
2019
Q1 | $4.82M | Buy |
+328,825
| New | +$4.82M | 2.29% | 17 |
|